APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Vaccine

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Selected research

Market Outlook & Growth Opportunities

Global Rabies Vaccine Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchRabies Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

Read the full market overview

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

This report provides an overview of the global Rabies Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rabies Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Rabies Vaccine Segment by Company

GSK (Novartis)

Sanofi-Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

Rabies Vaccine Segment by Type

Vero Cell Rabies Vaccine

BHK

Chick Embryo Cell Rabies Vaccine

Others

Rabies Vaccine Segment by Application

Pre-exposure Prophylaxis

Post-exposure Prophylaxis

Rabies Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rabies Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rabies Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rabies Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Rabies Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rabies Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Vaccine industry.

Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rabies Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rabies Vaccine Industry Trends Table 2. Rabies Vaccine Industry Drivers Table 3. Rabies Vaccine Industry Opportunities and Challenges Table 4. Rabies Vaccine Industry Restraints Table 5. Global Rabies Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rabies Vaccine Revenue Share by Company (2021-2026) Table 7. Global Rabies Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Rabies Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Rabies Vaccine Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Rabies Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rabies Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Rabies Vaccine Company, Product Type & Application Table 13. Global Rabies Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vero Cell Rabies Vaccine Table 18. Significant Companies of BHK Table 19. Significant Companies of Chick Embryo Cell Rabies Vaccine Table 20. Significant Companies of Others Table 21. Global Rabies Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Rabies Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Rabies Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Rabies Vaccine Sales Volume Share by Type (2021-2026) Table 25. Global Rabies Vaccine Sales Volume Share by Type (2027-2032) Table 26. Global Rabies Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rabies Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Rabies Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Rabies Vaccine Sales Value Share by Type (2021-2026) Table 30. Global Rabies Vaccine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pre-exposure Prophylaxis Table 32. Significant Companies of Post-exposure Prophylaxis Table 33. Global Rabies Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Rabies Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Rabies Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Rabies Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Rabies Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Rabies Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Rabies Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Rabies Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Rabies Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Rabies Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Rabies Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Rabies Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Rabies Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Rabies Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Rabies Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Rabies Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rabies Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Rabies Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Rabies Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Rabies Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Rabies Vaccine Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Rabies Vaccine Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Rabies Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Rabies Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Rabies Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Rabies Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Rabies Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Rabies Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Rabies Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Rabies Vaccine Sales Value Market Share by Country (2027-2032) Table 65. GSK (Novartis) Company Information Table 66. GSK (Novartis) Business Overview Table 67. GSK (Novartis) Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. GSK (Novartis) Rabies Vaccine Product Portfolio Table 69. GSK (Novartis) Recent Development Table 70. Sanofi-Pasteur Company Information Table 71. Sanofi-Pasteur Business Overview Table 72. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Sanofi-Pasteur Rabies Vaccine Product Portfolio Table 74. Sanofi-Pasteur Recent Development Table 75. Chengda Company Information Table 76. Chengda Business Overview Table 77. Chengda Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Chengda Rabies Vaccine Product Portfolio Table 79. Chengda Recent Development Table 80. Yisheng Company Information Table 81. Yisheng Business Overview Table 82. Yisheng Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Yisheng Rabies Vaccine Product Portfolio Table 84. Yisheng Recent Development Table 85. Prcmise Company Information Table 86. Prcmise Business Overview Table 87. Prcmise Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Prcmise Rabies Vaccine Product Portfolio Table 89. Prcmise Recent Development Table 90. VACN Company Information Table 91. VACN Business Overview Table 92. VACN Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. VACN Rabies Vaccine Product Portfolio Table 94. VACN Recent Development Table 95. Changsheng Company Information Table 96. Changsheng Business Overview Table 97. Changsheng Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Changsheng Rabies Vaccine Product Portfolio Table 99. Changsheng Recent Development Table 100. BCHT Company Information Table 101. BCHT Business Overview Table 102. BCHT Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. BCHT Rabies Vaccine Product Portfolio Table 104. BCHT Recent Development Table 105. Hissen Company Information Table 106. Hissen Business Overview Table 107. Hissen Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Hissen Rabies Vaccine Product Portfolio Table 109. Hissen Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Rabies Vaccine Distributors List Table 113. Rabies Vaccine Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Rabies Vaccine Product Image Figure 2. Global Rabies Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rabies Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Rabies Vaccine Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Rabies Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vero Cell Rabies Vaccine Image Figure 10. BHK Image Figure 11. Chick Embryo Cell Rabies Vaccine Image Figure 12. Others Image Figure 13. Global Rabies Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Rabies Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Rabies Vaccine Sales Volume Share by Type (2021-2032) Figure 16. Global Rabies Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rabies Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rabies Vaccine Sales Value Share by Type (2021-2032) Figure 19. Pre-exposure Prophylaxis Image Figure 20. Post-exposure Prophylaxis Image Figure 21. Global Rabies Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Rabies Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Rabies Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Rabies Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Rabies Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Rabies Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Rabies Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Rabies Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Rabies Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Rabies Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Rabies Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Rabies Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Rabies Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Rabies Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Rabies Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Rabies Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Rabies Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Rabies Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Rabies Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Rabies Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Rabies Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Others
Applications
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Companies covered
  • GSK (Novartis)
  • Sanofi-Pasteur
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rabies Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Rabies Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Rabies Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rabies Vaccine Market Dynamics
  1. 2.1 Rabies Vaccine Industry Trends
  2. 2.2 Rabies Vaccine Industry Drivers
  3. 2.3 Rabies Vaccine Industry Opportunities and Challenges
  4. 2.4 Rabies Vaccine Industry Restraints
3 Rabies Vaccine Market by Company
  1. 3.1 Global Rabies Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Rabies Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Rabies Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Rabies Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Rabies Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Rabies Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Rabies Vaccine Company Product Type and Application
  8. 3.8 Global Rabies Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rabies Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rabies Vaccine Market by Type
  1. 4.1 Rabies Vaccine Type Introduction
  2. 4.1.1 Vero Cell Rabies Vaccine
  3. 4.1.2 BHK
  4. 4.1.3 Chick Embryo Cell Rabies Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Rabies Vaccine Sales Volume by Type
  7. 4.2.1 Global Rabies Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Rabies Vaccine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Rabies Vaccine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Rabies Vaccine Sales Value by Type
  11. 4.3.1 Global Rabies Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Rabies Vaccine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Rabies Vaccine Sales Value Share by Type (2021-2032)
5 Rabies Vaccine Market by Application
  1. 5.1 Rabies Vaccine Application Introduction
  2. 5.1.1 Pre-exposure Prophylaxis
  3. 5.1.2 Post-exposure Prophylaxis
  4. 5.2 Global Rabies Vaccine Sales Volume by Application
  5. 5.2.1 Global Rabies Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Rabies Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Rabies Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Rabies Vaccine Sales Value by Application
  9. 5.3.1 Global Rabies Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Rabies Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Rabies Vaccine Sales Value Share by Application (2021-2032)
6 Rabies Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Rabies Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Rabies Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Rabies Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Rabies Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rabies Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rabies Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rabies Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Rabies Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rabies Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Rabies Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rabies Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Rabies Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rabies Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rabies Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rabies Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Rabies Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rabies Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rabies Vaccine Sales Value Share by Country, 2025 VS 2032
7 Rabies Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rabies Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rabies Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Rabies Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Rabies Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Rabies Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rabies Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rabies Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rabies Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rabies Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rabies Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rabies Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rabies Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rabies Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rabies Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rabies Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rabies Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rabies Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rabies Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rabies Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rabies Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rabies Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rabies Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rabies Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rabies Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rabies Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rabies Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rabies Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rabies Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rabies Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rabies Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rabies Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rabies Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rabies Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rabies Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rabies Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rabies Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rabies Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK (Novartis)
  2. 8.1.1 GSK (Novartis) Company Information
  3. 8.1.2 GSK (Novartis) Business Overview
  4. 8.1.3 GSK (Novartis) Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
  6. 8.1.5 GSK (Novartis) Recent Developments
  7. 8.2 Sanofi-Pasteur
  8. 8.2.1 Sanofi-Pasteur Company Information
  9. 8.2.2 Sanofi-Pasteur Business Overview
  10. 8.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
  12. 8.2.5 Sanofi-Pasteur Recent Developments
  13. 8.3 Chengda
  14. 8.3.1 Chengda Company Information
  15. 8.3.2 Chengda Business Overview
  16. 8.3.3 Chengda Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengda Rabies Vaccine Product Portfolio
  18. 8.3.5 Chengda Recent Developments
  19. 8.4 Yisheng
  20. 8.4.1 Yisheng Company Information
  21. 8.4.2 Yisheng Business Overview
  22. 8.4.3 Yisheng Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yisheng Rabies Vaccine Product Portfolio
  24. 8.4.5 Yisheng Recent Developments
  25. 8.5 Prcmise
  26. 8.5.1 Prcmise Company Information
  27. 8.5.2 Prcmise Business Overview
  28. 8.5.3 Prcmise Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Prcmise Rabies Vaccine Product Portfolio
  30. 8.5.5 Prcmise Recent Developments
  31. 8.6 VACN
  32. 8.6.1 VACN Company Information
  33. 8.6.2 VACN Business Overview
  34. 8.6.3 VACN Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 VACN Rabies Vaccine Product Portfolio
  36. 8.6.5 VACN Recent Developments
  37. 8.7 Changsheng
  38. 8.7.1 Changsheng Company Information
  39. 8.7.2 Changsheng Business Overview
  40. 8.7.3 Changsheng Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Changsheng Rabies Vaccine Product Portfolio
  42. 8.7.5 Changsheng Recent Developments
  43. 8.8 BCHT
  44. 8.8.1 BCHT Company Information
  45. 8.8.2 BCHT Business Overview
  46. 8.8.3 BCHT Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BCHT Rabies Vaccine Product Portfolio
  48. 8.8.5 BCHT Recent Developments
  49. 8.9 Hissen
  50. 8.9.1 Hissen Company Information
  51. 8.9.2 Hissen Business Overview
  52. 8.9.3 Hissen Rabies Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hissen Rabies Vaccine Product Portfolio
  54. 8.9.5 Hissen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rabies Vaccine Value Chain Analysis
  2. 9.1.1 Rabies Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rabies Vaccine Sales Mode & Process
  6. 9.2 Rabies Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rabies Vaccine Distributors
  9. 9.2.3 Rabies Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst